OMass Therapeutics

Director, Clinical Immunology

Oxford Hybrid Full time Posted Apr 29, 2026
LocationOxford
WorkplaceHybrid
EmploymentFull time
PostedApril 29, 2026
Last verifiedMay 6, 2026

OMass Therapeutics is a biotechnology company based in Oxford discovering medicines against highly- validated target ecosystems, such as membrane proteins or intracellular complexes. The company’s unique OdyssION™ technology platform comprises novel biochemistry techniques, next-generation native mass spectrometry, and custom chemistry. OMass is advancing a pipeline of small-molecule therapeutics in rare diseases and immunological conditions that target solute carriers, complex-bound proteins, and GPCRs.

We are seeking a Clinical Immunologist to join our team. You will be part of a dynamic, innovative environment and become an integral part of our vision to address patients’ unmet needs while building Britain’s Biggest Biotech. You will provide internal and external-facing immunology clinical development expertise and leadership for the OMass immunology portfolio, reporting to the VP, Clinical Development, and collaborating with a focused and caring team.

Discover the impactful work OMass delivers and explore our Employee Value Proposition here https://www.omass.com/working-here.

Role Overview

  • Partner with the Translational Pharmacology team to shape and deliver the company’s immunology strategy to develop a portfolio of differentiated and commercially viable immunology assets
  • Lead clinical development strategy, planning and execution for OMass pipeline of first-in-class immunology assets
  • Contribute to discovery and pre-clinical plans to deliver development candidates with highly differentiated target product profiles
  • Drive efforts to establish clinical biomarker plans to demonstrate early proof-of-mechanism and value generation for early immunology assets
  • Contribute to target identification and selection activities, including patient stratification strategies

Before you leave

Leave your email to track this opening and receive relevant alerts. You can also continue without sharing it.